It’s hard to remember a time before Ozempic, Wegovy, and other injectable drugs referred to as GLP-1 receptor agonists (that ...

New research shows that weight loss medications can stop the progression of prediabetes. Experts don’t all agree on such a ...

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...

Nearly three-quarters of U.S. adults are overweight or obese, according to a sweeping new study. The findings have wide-reaching implications for the nation’s health and medical costs as it faces a ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...

The national use of weight loss drugs like Ozempic and Wegovy more than doubled as bariatric surgery frequency dropped by ...

New studies to be presented at the American Heart Association meeting focus on disparities in Wegovy prescriptions and ...

GLP-1 Receptor Agonist medications, such as Ozempic, combined with exercise and nutrition, can help reduce obesity, according ...

Perceived high costs, inconsistent insurance coverage, and drug shortages have created barriers ... or overweight (body mass ...

Deaths from cardiovascular disease have surged among adults ages 25 to 64 living in rural areas, a new study shows.

Below, check out the roundup of California Healthline’s coverage. For today's national health news ... NCD and founder of a social media platform for brokers and agents called Insurance Forums, has ...